FutureChem Co (XKRX:220100) LT-Debt-to-Total-Asset : 0.06 (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FutureChem Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. FutureChem Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.06.

FutureChem Co's long-term debt to total assets ratio increased from Sep. 2023 (0.03) to Sep. 2024 (0.06). It may suggest that FutureChem Co is progressively becoming more dependent on debt to grow their business.

FutureChem Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for FutureChem Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FutureChem Co LT-Debt-to-Total-Asset Chart

FutureChem Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.24

0.19

0.15

0.02

0.04

FutureChem Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.04	0.04	0.03	0.06

FutureChem Co LT-Debt-to-Total-Asset Calculation

FutureChem Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	2619.795	/	72833.182
	=	0.04

FutureChem Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	4843.503	/	77831.713
	=	0.06

FutureChem Co (XKRX:220100) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

FutureChem Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of FutureChem Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

FutureChem Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FutureChem Co Ltd (XKRX:220100) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

2Floor, 21, Yeonmujang 3-gil, Seongdong-gu, Seoul, KOR, 04782

Website

http://www.futurechem.co.kr

FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.

FutureChem Co Headlines

No Headlines